Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Genprex (GNPX) 10K Form and Latest SEC Filings 2026

Genprex logo
$0.80 -0.03 (-3.05%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$0.81 +0.01 (+0.62%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Genprex SEC Filings & Recent Activity

Genprex (NASDAQ:GNPX) has submitted 329+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 14, 2026.

Form 4
Genprex, Inc. Reports Ownership Change on Apr. 15, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Genprex Files Current Report on May. 14, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Genprex Files Quarterly Report on May. 13, 2026

The 10-Q contains Genprex's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Genprex SEC Filing History

Browse Genprex's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/14/2026 7:05 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2026 3:35 PM
Genprex (1595248) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2026 4:52 PM
Ayrton Capital LLC (1698148) Filed by
Genprex (1595248) Subject
Form SCHEDULE 13G/A
04/30/2026 7:00 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 3:47 PM
Genprex (1595248) Filer
Form DEF 14A
04/29/2026 3:49 PM
Genprex (1595248) Filer
Form ARS
04/28/2026 6:07 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2026 6:02 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 3:34 PM
Genprex (1595248) Filer
Form PRE 14A
04/15/2026 5:50 PM
Genprex (1595248) Issuer
LONGNECKER BRENT M (1218777) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 4:34 PM
Genprex (1595248) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2026 6:03 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2026 5:33 PM
Confer Ryan M. (1735541) Reporting
Genprex (1595248) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:34 PM
Berger Mark Stanley (1700283) Reporting
Genprex (1595248) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 7:08 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 9:05 AM
Ayrton Capital LLC (1698148) Filed by
Genprex (1595248) Subject
Form SCHEDULE 13G
02/10/2026 7:04 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 3:56 PM
Genprex (1595248) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/09/2026 3:58 PM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 6:04 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2026 6:03 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2025 4:31 PM
Genprex (1595248) Issuer
Wilson William R Jr. (1807385) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 4:32 PM
Genprex (1595248) Issuer
LONGNECKER BRENT M (1218777) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 4:34 PM
Confer Ryan M. (1735541) Reporting
Genprex (1595248) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 4:35 PM
Berger Mark Stanley (1700283) Reporting
Genprex (1595248) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 4:35 PM
Genprex (1595248) Issuer
Moreno Toscano Jose Antonio (1807313) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 6:15 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2025 11:15 PM
Genprex (1595248) Filer
Form EFFECT
12/12/2025 3:41 PM
Genprex (1595248) Filer
Form 424B3
11/26/2025 3:31 PM
Genprex (1595248) Filer
Form S-1/A
11/26/2025 7:01 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2025 3:56 PM
Genprex (1595248) Filer
Form S-1
Registration statement under Securities Act of 1933  
11/21/2025 3:41 PM
Genprex (1595248) Filer
Form 424B5
11/21/2025 3:46 PM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2025 6:13 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2025 6:10 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2025 4:15 PM
Genprex (1595248) Filer
Form 424B5
11/04/2025 6:10 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2025 4:14 PM
Genprex (1595248) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G
10/29/2025 7:52 AM
Genprex (1595248) Filer
Form 424B5
10/29/2025 7:55 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
10/28/2025 7:19 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2025 7:26 AM
Genprex (1595248) Filer
Form 424B5
10/24/2025 7:26 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2025 6:05 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2025 6:10 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2025 8:00 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2025 11:15 PM
Genprex (1595248) Filer
Form EFFECT
09/16/2025 3:50 PM
Genprex (1595248) Filer
Form 424B3
09/12/2025 3:46 PM
Genprex (1595248) Filer
Form S-1
Registration statement under Securities Act of 1933  
08/20/2025 3:16 PM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2025 8:29 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025 8:07 AM
Genprex (1595248) Filer
Form RW
08/04/2025 7:38 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025 7:39 AM
Genprex (1595248) Filer
Form DEFA14A
07/16/2025 3:12 PM
Genprex (1595248) Filer
Form DEF 14A
07/16/2025 3:20 PM
Genprex (1595248) Filer
Form ARS
07/03/2025 3:46 PM
Genprex (1595248) Filer
Form PRE 14A
07/01/2025 4:51 PM
Confer Ryan M. (1735541) Reporting
Genprex (1595248) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025 4:52 PM
Berger Mark Stanley (1700283) Reporting
Genprex (1595248) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025 8:28 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025 8:12 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025 11:15 PM
Genprex (1595248) Filer
Form EFFECT
06/17/2025 3:25 PM
Genprex (1595248) Filer
Form 424B3
06/11/2025 4:24 PM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025 4:28 PM
Genprex (1595248) Filer
Form S-1
Registration statement under Securities Act of 1933  
06/09/2025 6:00 AM
Genprex (1595248) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Genprex SEC Filings - Frequently Asked Questions

Genprex (GNPX) has submitted 329+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Genprex's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 8-K submitted on May 14, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:GNPX) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners